Bernard Fermini

5.1k total citations · 1 hit paper
56 papers, 3.7k citations indexed

About

Bernard Fermini is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bernard Fermini has authored 56 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 43 papers in Molecular Biology and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bernard Fermini's work include Cardiac electrophysiology and arrhythmias (45 papers), Ion channel regulation and function (36 papers) and Neuroscience and Neural Engineering (17 papers). Bernard Fermini is often cited by papers focused on Cardiac electrophysiology and arrhythmias (45 papers), Ion channel regulation and function (36 papers) and Neuroscience and Neural Engineering (17 papers). Bernard Fermini collaborates with scholars based in United States, Canada and United Kingdom. Bernard Fermini's co-authors include Stanley Nattel, Zhiguo Wang, Anthony A. Fossa, Dayue Darrel Duan, Joseph J. Salata, David G. Strauss, Gary A. Gintant, Norman Stockbridge, Barbara A. Wible and David Fedida and has published in prestigious journals such as Circulation, Circulation Research and The Journal of Physiology.

In The Last Decade

Bernard Fermini

56 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress

2016 303 citations Thomas Colatsky, Bernard Fermini et al. Journal of Pharmacological and Toxicological Methods profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard Fermini United States	31	3.0k	2.8k	1.1k	196	172	56	3.7k
Leif Carlsson Sweden	28	2.8k 0.9×	2.3k 0.8×	473 0.5×	139 0.7×	125 0.7×	60	3.6k
Gary A. Gintant United States	36	3.6k 1.2×	3.3k 1.2×	1.3k 1.3×	377 1.9×	159 0.9×	98	4.9k
John S. Mitcheson United Kingdom	34	3.1k 1.0×	3.3k 1.2×	1.1k 1.1×	68 0.3×	78 0.5×	59	3.9k
Zhengfeng Zhou United States	28	3.1k 1.0×	3.4k 1.2×	871 0.8×	68 0.3×	53 0.3×	52	4.0k
William Crumb United States	25	1.7k 0.6×	1.6k 0.6×	540 0.5×	123 0.6×	64 0.4×	45	2.4k
Najah Abi‐Gerges United Kingdom	30	1.5k 0.5×	1.4k 0.5×	521 0.5×	215 1.1×	53 0.3×	63	2.1k
Göran Duker Sweden	26	1.7k 0.6×	1.4k 0.5×	321 0.3×	94 0.5×	93 0.5×	54	2.1k
Michael K. Pugsley United States	27	1.2k 0.4×	1.1k 0.4×	455 0.4×	195 1.0×	51 0.3×	119	2.6k
Yuri A. Kuryshev United States	27	1.3k 0.4×	1.6k 0.6×	604 0.6×	51 0.3×	47 0.3×	51	2.4k
José A. Sánchez‐Chapula Mexico	26	1.9k 0.6×	2.0k 0.7×	952 0.9×	34 0.2×	82 0.5×	75	2.5k

Countries citing papers authored by Bernard Fermini

Since Specialization

Citations

This map shows the geographic impact of Bernard Fermini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Fermini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Fermini more than expected).

Fields of papers citing papers by Bernard Fermini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Fermini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Fermini. The network helps show where Bernard Fermini may publish in the future.

Co-authorship network of co-authors of Bernard Fermini

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Fermini. A scholar is included among the top collaborators of Bernard Fermini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Fermini. Bernard Fermini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bell, Damian C. & Bernard Fermini. (2021). Use of automated patch clamp in cardiac safety assessment: Past, present & future perspectives. Journal of Pharmacological and Toxicological Methods. 111. 107114–107114. 8 indexed citations

Bell, Damian C. & Bernard Fermini. (2021). Use of automated patch clamp in cardiac safety assessment: past, present and future perspectives. Journal of Pharmacological and Toxicological Methods. 110. 107072–107072. 23 indexed citations

Hayes, Heather B., Stacie Chvatal, David Wolfson, et al.. (2019). Novel method for action potential measurements from intact cardiac monolayers with multiwell microelectrode array technology. Scientific Reports. 9(1). 11893–11893. 60 indexed citations

Fermini, Bernard, et al.. (2018). Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development. SLAS DISCOVERY. 23(8). 765–776. 41 indexed citations

Gintant, Gary A., Bernard Fermini, Norman Stockbridge, & David G. Strauss. (2017). The Evolving Roles of Human iPSC-Derived Cardiomyocytes in Drug Safety and Discovery. Cell stem cell. 21(1). 14–17. 56 indexed citations

Jenkinson, Stephen, Jason Cordes, Bernard Fermini, et al.. (2017). Cardiac sodium channel antagonism – Translation of preclinical in vitro assays to clinical QRS prolongation. Journal of Pharmacological and Toxicological Methods. 89. 9–18. 6 indexed citations

Windley, Monique J., Najah Abi‐Gerges, Bernard Fermini, et al.. (2017). Measuring kinetics and potency of hERG block for CiPA. Journal of Pharmacological and Toxicological Methods. 87. 99–107. 35 indexed citations

Huang, Hai, Michael K. Pugsley, Bernard Fermini, et al.. (2017). Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative. Journal of Pharmacological and Toxicological Methods. 87. 11–23. 50 indexed citations

Fermini, Bernard, et al.. (2016). L-type calcium channel antagonism – Translation from in vitro to in vivo. Journal of Pharmacological and Toxicological Methods. 84. 86–92. 9 indexed citations

10.

Colatsky, Thomas, Bernard Fermini, Gary A. Gintant, et al.. (2016). The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress. Journal of Pharmacological and Toxicological Methods. 81. 15–20. 303 indexed citations breakdown →

11.

Puppala, Dinesh, Leon P. Collis, Vinícius Bonato, et al.. (2012). Comparative Gene Expression Profiling in Human-Induced Pluripotent Stem Cell—Derived Cardiocytes and Human and Cynomolgus Heart Tissue. Toxicological Sciences. 131(1). 292–301. 37 indexed citations

12.

Watson, Kenny J., William Gorczyca, John P. Umland, et al.. (2011). Pharmacokinetic–pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods. 63(3). 304–313. 29 indexed citations

13.

Chaudhary, Khuram W., et al.. (2006). Evaluation of the Rubidium Efflux Assay for Preclinical Identification of hERG Blockade. Assay and Drug Development Technologies. 4(1). 73–82. 19 indexed citations

14.

Lagrutta, Armando, Jixin Wang, Bernard Fermini, & Joseph J. Salata. (2006). Novel, Potent Inhibitors of Human Kv1.5 K+ Channels and Ultrarapidly Activating Delayed Rectifier Potassium Current. Journal of Pharmacology and Experimental Therapeutics. 317(3). 1054–1063. 93 indexed citations

15.

Fossa, Anthony A., et al.. (2004). Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig. European Journal of Pharmacology. 486(2). 209–221. 64 indexed citations

16.

Fermini, Bernard & Anthony A. Fossa. (2003). The impact of drug-induced QT interval prolongation on drug discovery and development. Nature Reviews Drug Discovery. 2(6). 439–447. 359 indexed citations

17.

Fermini, Bernard, et al.. (1996). Adrenergic Modulation of Ultrarapid Delayed Rectifier K+ Current in Human Atrial Myocytes. Circulation Research. 110 indexed citations

18.

Fermini, Bernard, Nancy K. Jurkiewicz, Brian Jow, et al.. (1995). Use-Dependent Effects of the Class III Antiarrhythmic Agent NE-10064 (Azimilide) on Cardiac Repolarization. Journal of Cardiovascular Pharmacology. 26(2). 259–271. 102 indexed citations

19.

Wang, Zhiguo, Bernard Fermini, & Stanley Nattel. (1995). Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.. Journal of Pharmacology and Experimental Therapeutics. 272(1). 184–196. 145 indexed citations

20.

Wang, Zhiguo, Bernard Fermini, & Stanley Nattel. (1994). Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovascular Research. 28(10). 1540–1546. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact